ASPIRA

Aspira Pathlab & Diagnostics Share PriceAspira Pathlab & Diagnostics

₹42.95
1.95 (4.76%)
As on 08 February, 2023 | 10:07 BSE: 540788 NSE: ASPIRA

Aspira Pathlab & Diagnostics Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Aspira Pathlab & Diagnostics

Start SIP

Aspira Pathlab & Diagnostics Share Price

  • Over 1 Month 0%
  • Over 3 Month -1.15%
  • Over 6 Month -20.39%
  • Over 1 Year -47.59%

Aspira Pathlab & Diagnostics Key Statistics

Aspira Pathlab & Diagnostics Investment Rating

  • Master Rating:
  • Aspira Pathlab & Diag has an operating revenue of Rs. 16.84 Cr. on a trailing 12-month basis. An annual revenue growth of 27% is outstanding, Pre-tax margin of 23% is great, ROE of 56% is exceptional. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 9 which is a POOR score indicating inconsistency in earnings, a RS Rating of 15 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 148 indicates it belongs to a poor industry group of Medical-Services and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Aspira Pathlab & Diagnostics Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 435
Operating Expenses Qtr Cr 333
Operating Profit Qtr Cr 002
Depreciation Qtr Cr 001
Interest Qtr Cr 000
Tax Qtr Cr 000
Net Profit Qtr Cr 001

Aspira Pathlab & Diagnostics Technicals

EMA & SMA

Current Price
₹42.95
1.95 (4.76%)
  • Bullish Moving Average
  • ___
  • 12
  • Bearish Moving Average
  • ___
  • 4
  • 20 Day
  • 41.11
  • 50 Day
  • 41.77
  • 100 Day
  • 43.55
  • 200 Day
  • 47.49
  • 20 Day
  • 41.32
  • 50 Day
  • 41.67
  • 100 Day
  • 42.36
  • 200 Day
  • 47.19

Aspira Pathlab & Diagnostics Resistance and Support

PIVOT
₹40.46
Resistance
First Resistance 42.55
Second Resistance 44.1
Third Resistance 46.2
RSI 48.42
MFI 11.3
MACD Single Line -0.32
MACD -0.44
Support
First Resistance 38.9
Second Resistance 36.8
Third Resistance 35.25

Aspira Pathlab & Diagnostics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,482 138,004 93.12
Week 1,759 159,383 90.61
1 Month 4,552 394,509 86.67
6 Month 33,586 2,938,436 87.49

Aspira Pathlab & Diagnostics Result Highlights

Aspira Pathlab & Diagnostics Synopsis

BSE-Medical-Services

Aspira Pathlab & Dia is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 19.54 Cr. and Equity Capital is Rs. 10.29 Cr. for the Year ended 31/03/2022. Aspira Pathlab & Diagnostics Ltd. is a Public Limited Listed company incorporated on 03/07/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85100MH1973PLC289209 and registration number is 289209.
Market Cap 42
Sales 17
Shares in Float 0.83
No of funds
Yield
Book Value 5.37
U/D Vol ratio 1.1
LTDebt / Equity 11
Alpha -0.24
Beta 0.03

Aspira Pathlab & Diagnostics

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 19.48%34.55%36.19%
Individual Investors 52.61%40.91%43.33%
Others 27.91%24.54%20.48%

Aspira Pathlab & Diagnostics Management

Name Designation
Dr. Haseeb Drabu Chairman & Ind.Director
Dr. Pankaj J Shah Managing Director & CEO
Mr. Arvind Karsandas Bhanushali Executive Director
Mr. Nikunj Mange Executive Director
Dr. Subhash Raghunath Salunke Independent Director
Mrs. Mangala K Prabhu Independent Director
Mr. Avinash C Mahajan Independent Director

Aspira Pathlab & Diagnostics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Aspira Pathlab & Diagnostics FAQs

What is Share Price of Aspira Pathlab & Diagnostics ?

Aspira Pathlab & Diagnostics share price is ₹42 As on 08 February, 2023 | 09:53

What is the Market Cap of Aspira Pathlab & Diagnostics ?

The Market Cap of Aspira Pathlab & Diagnostics is ₹44.2 Cr As on 08 February, 2023 | 09:53

What is the P/E ratio of Aspira Pathlab & Diagnostics ?

The P/E ratio of Aspira Pathlab & Diagnostics is 21.6 As on 08 February, 2023 | 09:53

What is the PB ratio of Aspira Pathlab & Diagnostics ?

The PB ratio of Aspira Pathlab & Diagnostics is 5.6 As on 08 February, 2023 | 09:53

Q2FY23